IUD market seen reaching $4.78 billion by 2030

The intra-uterine contraceptive devices market is projected to grow from $3.45 billion in 2025 to $4.78 billion by 2030 as family planning awareness, reproductive health access and long-acting contraception adoption rise. North America led the market in 2025, while Asia-Pacific is expected to grow fastest.

Why it matters: - The intra-uterine contraceptive devices market is expanding because demand is rising for long-acting, user-independent contraception. - Growth in reproductive health access could improve family planning, reduce unintended pregnancies and widen contraceptive choice in more countries. - The market’s long-term outlook points to continued investment in hormonal, bioactive and biocompatible device technologies.

What happened: - The market is projected to rise from $3.45 billion in 2025 to $3.68 billion in 2026, a 6.5% CAGR. - The market is expected to reach $4.78 billion by 2030, growing at a 6.8% CAGR. - North America held the largest market share in 2025. - Asia-Pacific is forecast to grow at the fastest pace in the coming years. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, and the Middle East and Africa.

The details: - Family planning awareness, government population-control initiatives and stronger reproductive health services are among the main growth drivers. - Better access to gynecological clinics and maternal care is supporting adoption. - Improvements in healthcare infrastructure in developing countries are expanding market reach. - Demand is increasing for minimally invasive and user-independent contraceptive devices. - Adoption is rising for advanced hormonal and bioactive intrauterine systems. - Innovation in biocompatible and drug-eluting technologies is expected to support future growth. - The source defines intrauterine contraceptive devices as small medical devices placed inside the uterine cavity to provide long-acting and reversible contraception. - The devices work by creating a localized environment that hinders fertilization and by modifying the endometrial lining. - In certain clinical settings, the devices may also be used under medical guidance to manage menstrual-related conditions. - A World Health Organization 2025 report said about 874 million women worldwide were using modern contraceptive methods. - The same report projected that another 70 million women will gain access to family planning services by 2030. - A free sample of the report is available here. - The full report is available here.

Between the lines: - Robotics-assisted insertion could make procedures more precise and more comfortable for patients. - Industry 4.0 tools are being folded into contraceptive manufacturing to improve automation and efficiency. - IoT-enabled tracking and inventory systems are gaining traction for supply chain visibility and device monitoring. - Blockchain is being explored to improve traceability and transparency across contraceptive supply chains. - Mobile reproductive healthcare outreach supported by electric mobility platforms could extend access in remote and underserved areas.

What's next: - Market growth will likely track broader access to reproductive healthcare and continued public-health campaigns around family planning. - Companies that advance smart manufacturing, traceability and distribution may gain an edge as the market matures. - Regional expansion in Asia-Pacific could become a major driver of future demand.

The bottom line: - The IUD market is moving from steady growth to broader global expansion, with access, innovation and long-acting contraception demand shaping the next phase.